Non-steroidal anti-inflammatory drugs and risk of mortality in lung cancer: A meta-analysis of 5 prospective cohorts studies

Medicine
Yifei ChenYing Zhu

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) especially aspirin has been gained increasing attention due to its potential therapy against to lung cancer. Previous investigations have showed different findings in this issue. We studied the safety profile and efficacy of NSAIDs in treating lung cancer. Embase, Pubmed, and Cochrane Library databases were searched from January 2011 to February 2019. We identified the studies meeting a priori inclusion criteria and it also conducted a secondary review. This meta-analysis of 5 prospective studies was launched to evaluate the effect of NSAIDs for patients with lung cancer on the hazard risk (HR). We used the Random-Effect Model to assess pooled HR and between-study heterogeneity. Application of subgroup analysis, meta-regression, as well as sensitivity analysis was to pinpoint the exact sources of the observed heterogeneity. 5 Prospective Cohorts Studies, including 6017 patients with lung cancer were recruited in the final meta-analysis. In general, using of NSAIDs especially aspirin is not associated with mortality of lung cancer: pooled hazard ratio (HR) of 0.88 [95% confidence intervals (CI): 0.73-1.05] with low heterogeneity (Q = 6.95; I = 42.4%, P = .139). Egger (P = .665) and ...Continue Reading

References

Sep 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·G J GasicC C Stewart
Feb 21, 2002·Journal of the National Cancer Institute·Michael J ThunCarlo Patrono
Apr 4, 2007·Cancer Causes & Control : CCC·Marilyn L KwanBette Caan
Jun 28, 2007·British Journal of Cancer·N HelbekkmoUNKNOWN Norwegian Lung Cancer Study Group
Nov 4, 2008·Breast Cancer Research and Treatment·Ya-shuang ZhaoXia Li
Feb 14, 2009·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·Cristina BosettiCarlo La Vecchia
May 13, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bjørn H GrønbergStein Sundstrøm
Aug 22, 2009·Schizophrenia Research·Chris J BusheRichard E Hodgson
Feb 18, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michelle D HolmesSusan E Hankinson
Sep 17, 2010·Gut·Farhat V N DinMalcolm G Dunlop
Nov 3, 2010·Journal of Thrombosis and Haemostasis : JTH·N M Bambace, C E Holmes
Aug 29, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kevin S ChoeStanley L Liauw
Sep 7, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sverre SörensonBirgitta Clinchy
Oct 12, 2013·Current Oncology Reports·Mangesh A Thorat, Jack Cuzick
Apr 11, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K M KerrUNKNOWN Panel Members
Oct 8, 2014·Evidence-based Mental Health·Anna ChaimaniGeorgia Salanti
Nov 30, 2014·Journal of the National Cancer Institute·Kimmie NgCharles S Fuchs
Jun 30, 2015·Environmental Microbiology·Ramon MassanaColomban de Vargas
Nov 18, 2015·BMC Cancer·Úna C Mc MenaminLiam M Murray
May 14, 2017·Scientific Reports·Xiaoping ZhaoHaoseng Li
Jul 27, 2018·Research and Practice in Thrombosis and Haemostasis·Kenji YokoyamaUNKNOWN JPPP study group
Sep 1, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K M KerrUNKNOWN Panel Members

❮ Previous
Next ❯

Software Mentioned

STATA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.